Janux Therapeutics JANX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's software and technology licenses, net?
- Janux Therapeutics (JANX) reported software and technology licenses, net of $3.94M in Q1 2026.
- How has Janux Therapeutics's software and technology licenses, net changed year-over-year?
- Janux Therapeutics's software and technology licenses, net increased by 41.3% year-over-year, from $2.79M to $3.94M.